Liye Zhong

444 total citations
29 papers, 239 citations indexed

About

Liye Zhong is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Liye Zhong has authored 29 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Hematology and 10 papers in Oncology. Recurrent topics in Liye Zhong's work include Immune Cell Function and Interaction (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Liye Zhong is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers) and Multiple Myeloma Research and Treatments (5 papers). Liye Zhong collaborates with scholars based in China, Germany and Australia. Liye Zhong's co-authors include Yangqiu Li, Shaohua Chen, Lijian Yang, Suxia Geng, Jing Zhang, Yang Wang, Xianfeng Zha, Nan‐Nan Yu, Qing‐Yu He and Yue Sun and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Liye Zhong

24 papers receiving 239 citations

Peers

Liye Zhong
Yehua Jin China
Emilia Pardal Spain
Teodora Statuto Italy
Eugenio Lucia Italy
Katy Billot France
Vassilios Aslanis United States
Yuandong Zhu China
Yuhta Oyama Japan
Ifra Mushtaq India
Dhananjay Kumar India
Yehua Jin China
Liye Zhong
Citations per year, relative to Liye Zhong Liye Zhong (= 1×) peers Yehua Jin

Countries citing papers authored by Liye Zhong

Since Specialization
Citations

This map shows the geographic impact of Liye Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liye Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liye Zhong more than expected).

Fields of papers citing papers by Liye Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liye Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liye Zhong. The network helps show where Liye Zhong may publish in the future.

Co-authorship network of co-authors of Liye Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Liye Zhong. A scholar is included among the top collaborators of Liye Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liye Zhong. Liye Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Xiaolong, Juan Wu, Haoqi Zhang, et al.. (2025). UVB radiation and amphibian resilience: Analyzing skin color, immune suppression and oxidative stress in Rana kukunoris from different elevations. Ecotoxicology and Environmental Safety. 294. 118075–118075. 4 indexed citations
2.
3.
Li, Sheng, Jianteng Xie, Xiaojie Chen, et al.. (2025). Outcomes of BTD vs. BCD as initial treatment of renal amyloid light-chain amyloidosis: a retrospective cohort study in China. Renal Failure. 47(1). 2453006–2453006.
4.
5.
6.
Wang, Xianfeng, Shuxin Zhong, Liye Zhong, et al.. (2024). BET Inhibitor JQ1 Selectively Reduce Tregs by Upregulating STAT3 and Suppressing PD‐1 Expression in Patients with Multiple Myeloma. Advanced Biology. 8(7). e2300640–e2300640. 3 indexed citations
7.
Wang, Jinghua, et al.. (2024). Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets. SHILAP Revista de lepidopterología. 6(1). e00181–e00181. 2 indexed citations
8.
Shi, Yuankai, Jie Cui, Hui Zhou, et al.. (2023). Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003). Cancer Immunology Immunotherapy. 72(9). 2991–3002. 2 indexed citations
9.
Wang, Jinghua, et al.. (2022). Incidence and effect of secondary cardiac amyloidosis on outcomes of patients with t(11;14) multiple myeloma. Frontiers in Cardiovascular Medicine. 9. 994384–994384.
10.
Wu, Xinyi, Sheng Li, Liwen Li, et al.. (2022). Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study. The International Journal of Cardiovascular Imaging. 38(7). 1519–1532. 17 indexed citations
11.
Yu, Fang, Ning Su, Shu‐Yun Ma, et al.. (2022). Optimization of high-dose methotrexate prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma: a multicenter analysis. Annals of Hematology. 101(3). 595–605. 3 indexed citations
12.
An, Gang, Daobin Zhou, Shu Cheng, et al.. (2021). A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia. Clinical Cancer Research. 27(20). 5492–5501. 25 indexed citations
13.
Cai, Jun, Xiao‐Peng Tian, Shu‐Yun Ma, et al.. (2021). A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study. British Journal of Cancer. 125(3). 402–412. 11 indexed citations
14.
Li, Miao, Lin Qi, Liye Zhong, et al.. (2020). Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma. Molecular Therapy — Oncolytics. 19. 197–207. 8 indexed citations
15.
Zhang, Jing, Yue Sun, Liye Zhong, et al.. (2020). Structure-based discovery of neoandrographolide as a novel inhibitor of Rab5 to suppress cancer growth. Computational and Structural Biotechnology Journal. 18. 3936–3946. 25 indexed citations
16.
Wang, Yulian, Peilong Lai, Xiaomei Chen, et al.. (2017). Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg. Scientific Reports. 7(1). 3603–3603. 9 indexed citations
17.
Chen, Xiaomei, Jianyu Weng, Yulian Wang, et al.. (2015). Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia. Blood. 126(23). 4897–4897. 2 indexed citations
18.
Chen, Shaohua, Qi Shen, Lijian Yang, et al.. (2010). Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. Journal of Hematology & Oncology. 3(1). 44–44. 29 indexed citations
19.
Zhong, Liye, Tianhao Liu, Yangqiu Li, et al.. (2009). [Serum proteomics in patients with RAEB myelodysplastic syndromes].. PubMed. 29(9). 1799–801. 2 indexed citations
20.
Li, Yangqiu, Lijian Yang, Shaohua Chen, et al.. (2008). Reduced levels of recent thymic emigrants in acute myeloid leukemia patients. Cancer Immunology Immunotherapy. 58(7). 1047–1055. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yehua Jin Breakdown of academic impact, for papers by Emilia Pardal Breakdown of academic impact, for papers by Teodora Statuto Breakdown of academic impact, for papers by Eugenio Lucia Breakdown of academic impact, for papers by Katy Billot Breakdown of academic impact, for papers by Vassilios Aslanis Breakdown of academic impact, for papers by Yuandong Zhu Breakdown of academic impact, for papers by Yuhta Oyama Breakdown of academic impact, for papers by Ifra Mushtaq Breakdown of academic impact, for papers by Dhananjay Kumar
Rankless by CCL
2026